This is a combination of two of the most studied tissue-repair peptides — BPC-157 and TB-500 — supplied together in one preparation. Each has its own full profile; this page explains why they’re so often paired.
What you’re reading about
- BPC-157 — a pentadecapeptide studied for angiogenesis and musculoskeletal/gut repair. Read the BPC-157 profile →
- TB-500 — a Thymosin β-4 fragment studied for actin regulation, cell migration, and repair. Read the TB-500 profile →
The rationale
The two are frequently combined because their mechanisms are complementary: BPC-157 research centers on blood-vessel formation and growth-factor signaling, while TB-500 research centers on cell migration and cytoskeletal dynamics. Together they touch different stages of the tissue-repair process.
Research outlook
As with any combination, the pairing itself has not been studied in dedicated clinical trials — its rationale rests on the research behind each peptide. For the mechanisms, human-trial status, and citations, see the two individual profiles linked above.
